Back to mobile site

Barclays Starts Intellia Therapeutics (NTLA) at Underweight

October 6, 2026 6:11 AM EDT Send to a Friend
Barclays analyst Gena Wang initiates coverage on Intellia Therapeutics (NASDAQ: NTLA) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login